Home › Funds › Sequent Asset Management, LLC › DGX
Sequent Asset Management, LLC position in DGX
QUEST DIAGNOSTICS INC · Health Care
Sequent Asset Management, LLC reported holding 2,336 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$495K, representing 0.62% of its reported portfolio and ranking #32 among its reported holdings. Sequent Asset Management, LLC has disclosed DGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sequent Asset Management, LLC's DGX position evolved
Sequent Asset Management, LLC first disclosed a stake in DGX in Q3 2023 at 4,942 shares (US$602K). Across 12 filings, Sequent Asset Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 2,336 shares valued at US$495K — a reduction of -356 shares quarter over quarter.. Notable position changes include a 40% trim in Q4 2023 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.94K | $602.23K | New |
| Q4 2023 | 2.94K | $405.64K | Reduce |
| Q1 2024 | 2.69K | $358.00K | Reduce |
| Q2 2024 | 2.69K | $368.48K | Hold |
| Q3 2024 | 2.69K | $417.93K | Hold |
| Q4 2024 | 2.69K | $406.12K | Hold |
| Q1 2025 | 2.69K | $455.49K | Hold |
| Q2 2025 | 2.69K | $483.56K | Hold |
| Q3 2025 | 2.69K | $513.04K | Hold |
| Q4 2025 | 2.69K | $467.00K | Hold |
| Q1 2026 | 2.69K | $527.58K | Hold |
| Q2 2026 | 2.34K | $495.12K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
- M&G Plc 795.65K sh · $168.68M · Q2 2026
More on Sequent Asset Management, LLC
FAQ
How long has Sequent Asset Management, LLC held DGX?
Sequent Asset Management, LLC has disclosed DGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Sequent Asset Management, LLC's current position in DGX?
As of Q2 2026, Sequent Asset Management, LLC holds 2.34K shares of DGX (QUEST DIAGNOSTICS INC), valued at $495.12K, representing 0.62% of its reported portfolio and ranking #32.
Has Sequent Asset Management, LLC been buying or selling DGX?
In the latest 13F filing (Q2 2026), Sequent Asset Management, LLC reduced its position in DGX.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.